Induced pluripotent stem cells

Definition

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell generated from adult somatic cells through the introduction of specific transcription factors, allowing these cells to regain the ability to differentiate into any cell type. This groundbreaking technique has revolutionized regenerative medicine and opened new avenues for research and therapy by providing a more ethical and versatile source of stem cells compared to embryonic stem cells.

5 Must Know Facts For Your Next Test

1. iPSCs were first generated in 2006 by Shinya Yamanaka, who identified four key transcription factors (Oct4, Sox2, Klf4, and c-Myc) necessary for reprogramming adult cells.
2. Unlike embryonic stem cells, iPSCs can be created from a patient's own cells, reducing the risk of immune rejection when used for therapies.
3. iPSCs have broad applications in drug discovery, disease modeling, and personalized medicine, as they can be derived from individuals with specific genetic conditions.
4. Research on iPSCs is paving the way for innovative treatments for various diseases, including neurodegenerative disorders and cardiovascular diseases.
5. Concerns regarding the potential formation of tumors and ethical issues surrounding the use of reprogramming techniques remain important areas of ongoing research.

Review Questions

• What are the key benefits of using induced pluripotent stem cells compared to traditional sources of stem cells?
  • Induced pluripotent stem cells offer several advantages over traditional sources like embryonic stem cells. They can be derived from adult somatic cells, which means they eliminate ethical concerns associated with embryo destruction. Additionally, since iPSCs can be generated from a patient's own cells, they significantly reduce the risk of immune rejection when used in therapies. This versatility allows for personalized medicine approaches and expands the potential applications in regenerative medicine.
• How do transcription factors play a role in the generation of induced pluripotent stem cells?
  • Transcription factors are critical in the reprogramming process that converts adult somatic cells into induced pluripotent stem cells. The introduction of specific transcription factors, such as Oct4, Sox2, Klf4, and c-Myc, leads to the activation of pluripotency-associated genes while silencing differentiation pathways. This regulatory mechanism allows the somatic cells to revert to a pluripotent state where they can differentiate into various cell types, making transcription factors essential for creating iPSCs.
• Evaluate the potential implications of induced pluripotent stem cells on future regenerative medicine therapies and ethical considerations.
  • Induced pluripotent stem cells hold tremendous potential for advancing regenerative medicine by providing a patient-specific source of pluripotent cells that can be used for developing personalized therapies. They could lead to breakthroughs in treating a wide range of diseases and injuries by generating replacement tissues and organs. However, ethical considerations persist regarding the safety of iPSC therapies, particularly concerning tumor formation risks and informed consent during cell reprogramming. Balancing innovation with ethical responsibility will be crucial as research progresses in this promising field.

Related terms

Pluripotency: The ability of a stem cell to develop into any cell type in the body, excluding extra-embryonic tissues.

Reprogramming: The process of converting specialized adult cells back into a pluripotent state, enabling them to differentiate into various cell types.

Transcription factors: Proteins that help regulate the expression of genes, playing a crucial role in the reprogramming of somatic cells into iPSCs.